Upgrades:
B. Riley upgraded shares of Brunswick (NYSE:BC) from a neutral rating to a buy rating in a research note issued to investors on Tuesday, Marketbeat reports. B. Riley currently has $108.00 target price on the stock, up from their prior target price of $100.00.
BC has been the topic of several other reports. Morgan Stanley dropped their target price on Brunswick from $84.00 to $77.00 and set an equal weight rating on the stock in a report on Friday, October 27th. Raymond James lowered Brunswick from an outperform rating to a market perform rating in a report on Thursday, January 4th. StockNews.com raised Brunswick from a hold rating to a buy rating in a report on Friday, October 27th. Truist Financial dropped their price objective on Brunswick from $115.00 to $105.00 and set a buy rating on the stock in a report on Friday, February 2nd. Finally, Roth Mkm raised their price objective on Brunswick from $85.00 to $94.00 and gave the company a buy rating in a report on Friday, February 2nd. Three analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of Moderate Buy and an average target price of $95.09. Read more …
Norfolk Southern (NYSE:NSC) was upgraded by analysts at Barclays from an "equal weight" rating to an "overweight" rating in a research report issued on Wednesday, Marketbeat Ratings reports. The firm currently has a $305.00 price target on the railroad operator's stock, up from their prior price target of $255.00. Barclays's price target points to a potential upside of 20.15% from the stock's current price.
A number of other equities analysts also recently issued reports on the stock. Stifel Nicolaus downgraded shares of Norfolk Southern from a "buy" rating to a "hold" rating and dropped their price objective for the company from $250.00 to $233.00 in a research note on Monday, January 29th. Sanford C. Bernstein upgraded shares of Norfolk Southern from a "market perform" rating to an "outperform" rating and set a $272.00 price objective on the stock in a research note on Monday, January 22nd. Bank of America upgraded shares of Norfolk Southern from a "neutral" rating to a "buy" rating and increased their price objective for the company from $204.00 to $248.00 in a research note on Friday, December 1st. UBS Group increased their price objective on shares of Norfolk Southern from $209.00 to $238.00 and gave the company a "neutral" rating in a research note on Monday, January 29th. Finally, Morgan Stanley downgraded shares of Norfolk Southern from an "equal weight" rating to an "underweight" rating and dropped their price objective for the company from $185.00 to $175.00 in a research note on Monday, January 29th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $243.06. Read more …
Church & Dwight (NYSE:CHD) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating in a report issued on Friday, MarketBeat Ratings reports. The firm currently has a $115.00 price objective on the stock. Argus' target price suggests a potential upside of 15.42% from the company's current price.
CHD has been the topic of a number of other reports. The Goldman Sachs Group cut their target price on shares of Church & Dwight from $100.00 to $89.00 and set a "neutral" rating on the stock in a research note on Monday, November 6th. Barclays increased their price target on shares of Church & Dwight from $76.00 to $80.00 and gave the company an "underweight" rating in a research note on Tuesday, February 6th. TheStreet upgraded shares of Church & Dwight from a "c+" rating to a "b" rating in a research note on Friday, February 2nd. Royal Bank of Canada increased their price target on shares of Church & Dwight from $94.00 to $103.00 and gave the company a "sector perform" rating in a research note on Monday, February 5th. Finally, Citigroup lowered shares of Church & Dwight from a "neutral" rating to a "sell" rating and set a $90.00 price target on the stock. in a research note on Wednesday, December 13th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, Church & Dwight currently has an average rating of "Hold" and an average price target of $101.40. Read more ...
Downgrades:
BMO Capital Markets cut shares of Canadian Tire (TSE:CTC.A) from an outperform rating to a market perform rating in a research report sent to investors on Tuesday morning, BayStreet.CA reports. They currently have C$150.00 target price on the stock, down from their previous target price of C$170.00.
A number of other research firms have also recently issued reports on CTC.A. TD Securities dropped their price objective on Canadian Tire from C$160.00 to C$155.00 and set a hold rating for the company in a report on Friday, February 16th. CIBC dropped their price objective on Canadian Tire from C$153.00 to C$150.00 and set a neutral rating for the company in a report on Friday, February 16th. Canaccord Genuity Group cut Canadian Tire from a buy rating to a hold rating and dropped their price objective for the company from C$167.00 to C$154.00 in a report on Wednesday, February 7th. Desjardins dropped their price objective on Canadian Tire from C$170.00 to C$160.00 and set a buy rating for the company in a report on Friday, February 16th. Finally, National Bankshares dropped their price objective on Canadian Tire from C$152.00 to C$146.00 and set a sector perform rating for the company in a report on Friday, February 16th. Five research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of Hold and a consensus price target of C$162.44. Read more ...
Evercore ISI lowered shares of Caterpillar (NYSE:CAT) from an outperform rating to an in-line rating in a report issued on Tuesday morning, MarketBeat Ratings reports. Evercore ISI currently has $338.00 target price on the industrial products company’s stock, up from their prior target price of $321.00.
Several other research firms have also issued reports on CAT. Morgan Stanley initiated coverage on Caterpillar in a research note on Monday, January 8th. They set an equal weight rating and a $270.00 price objective for the company. The Goldman Sachs Group raised their price target on Caterpillar from $274.00 to $357.00 and gave the company a buy rating in a research report on Tuesday, February 6th. StockNews.com upgraded Caterpillar from a buy rating to a strong-buy rating in a research report on Monday, February 12th. TD Cowen raised their price target on Caterpillar from $300.00 to $338.00 and gave the company an outperform rating in a research report on Tuesday, February 6th. Finally, Stifel Nicolaus raised their price target on Caterpillar from $285.00 to $293.00 and gave the company a buy rating in a research report on Tuesday, December 19th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Hold and a consensus price target of $292.78. Read more ...
Redburn Atlantic cut shares of MSCI (NYSE:MSCI) from a neutral rating to a sell rating in a research note issued to investors on Tuesday morning, MarketBeat reports. They currently have $470.00 target price on the technology company’s stock, down from their prior target price of $620.00.
A number of other brokerages also recently issued reports on MSCI. Wells Fargo & Company increased their price target on MSCI from $615.00 to $660.00 and gave the stock an overweight rating in a research report on Wednesday, January 31st. The Goldman Sachs Group increased their target price on MSCI from $544.00 to $617.00 and gave the company a neutral rating in a report on Wednesday, January 31st. Edward Jones assumed coverage on MSCI in a report on Friday, December 22nd. They set a buy rating for the company. Morgan Stanley raised MSCI from an equal weight rating to an overweight rating and increased their target price for the company from $526.00 to $600.00 in a report on Wednesday, December 13th. Finally, Barclays increased their target price on MSCI from $600.00 to $700.00 and gave the company an overweight rating in a report on Wednesday, January 31st. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of Hold and an average target price of $578.21. Read more ...
Loop Capital lowered shares of W.W. Grainger (NYSE:GWW) from a buy rating to a hold rating in a research report released on Tuesday, MarketBeat.com reports. They currently have $1,000.00 price target on the industrial products company’s stock, up from their previous price target of $925.00.
A number of other analysts have also commented on GWW. Stephens boosted their price target on shares of W.W. Grainger from $775.00 to $1,000.00 and gave the company an equal weight rating in a research note on Tuesday, February 6th. JPMorgan Chase & Co. boosted their price target on shares of W.W. Grainger from $800.00 to $925.00 and gave the company a neutral rating in a research note on Tuesday, February 6th. Oppenheimer boosted their price target on shares of W.W. Grainger from $800.00 to $930.00 and gave the company an outperform rating in a research note on Wednesday, January 3rd. StockNews.com upgraded shares of W.W. Grainger from a hold rating to a buy rating in a research note on Tuesday, February 13th. Finally, Jefferies Financial Group lowered shares of W.W. Grainger from a buy rating to a hold rating and set a $825.00 price target for the company. in a research note on Wednesday, December 20th. One research analyst has rated the stock with a sell rating, six have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of Hold and a consensus price target of $864.44. Read more …
Home Depot (NYSE:HD) was downgraded by research analysts at HSBC from a "hold" rating to a "reduce" rating in a research note issued to investors on Wednesday, Briefing.com reports. They currently have a $323.00 price target on the home improvement retailer's stock. HSBC's target price would suggest a potential downside of 10.93% from the stock's current price.
Several other research firms have also weighed in on HD. The Goldman Sachs Group boosted their price target on Home Depot from $347.00 to $393.00 and gave the stock a "buy" rating in a research report on Tuesday, February 13th. Barclays upgraded Home Depot from an "equal weight" rating to an "overweight" rating and lifted their target price for the stock from $325.00 to $372.00 in a research note on Thursday, January 4th. Piper Sandler upgraded Home Depot from a "neutral" rating to an "overweight" rating and boosted their price target for the company from $311.00 to $400.00 in a research note on Tuesday, January 16th. StockNews.com upgraded Home Depot from a "hold" rating to a "buy" rating in a research report on Thursday, February 15th. Finally, Wedbush upgraded Home Depot from a "neutral" rating to an "outperform" rating and upped their target price for the company from $330.00 to $380.00 in a research report on Wednesday, January 10th. One analyst has rated the stock with a sell rating, nine have given a hold rating and nineteen have given a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $353.79. Read more …
Allegion (NYSE:ALLE) was downgraded by equities researchers at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating in a research note issued to investors on Wednesday, Marketbeat Ratings reports. They presently have a $140.00 price objective on the scientific and technical instruments company's stock, up from their prior price objective of $139.00. Wells Fargo & Company's price target points to a potential upside of 6.03% from the stock's previous close.
Separately, Barclays downgraded shares of Allegion from an "overweight" rating to an "equal weight" rating and decreased their price target for the stock from $130.00 to $119.00 in a research report on Monday, December 4th. Six equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $122.43.
ALLE opened at $132.04 on Wednesday. The firm has a market capitalization of $11.59 billion, a P/E ratio of 20.93, a P/E/G ratio of 3.85 and a beta of 1.14. The firm's 50 day moving average is $124.78 and its 200-day moving average is $112.28. Allegion has a 52-week low of $95.94 and a 52-week high of $136.91. The company has a quick ratio of 1.31, a current ratio of 2.03 and a debt-to-equity ratio of 1.63. Read more …
Eli Lilly and Company (NYSE:LLY) was downgraded by analysts at DZ Bank from a "buy" rating to a "hold" rating in a research note issued on Wednesday, Marketbeat.com reports. They currently have a $820.00 price target on the stock. DZ Bank's price target would indicate a potential upside of 8.50% from the stock's previous close.
LLY has been the topic of several other research reports. BMO Capital Markets boosted their target price on shares of Eli Lilly and Company from $710.00 to $865.00 and gave the stock an "outperform" rating in a report on Wednesday, February 7th. Barclays raised their target price on shares of Eli Lilly and Company from $680.00 to $810.00 and gave the stock an "overweight" rating in a report on Wednesday, February 7th. Deutsche Bank Aktiengesellschaft started coverage on shares of Eli Lilly and Company in a research note on Thursday, November 9th. They issued a "hold" rating and a $535.00 price target on the stock. Morgan Stanley raised their price target on shares of Eli Lilly and Company from $805.00 to $950.00 and gave the stock an "overweight" rating in a research note on Friday, February 16th. Finally, Cantor Fitzgerald reissued an "overweight" rating and set a $815.00 target price on shares of Eli Lilly and Company in a research report on Tuesday. Three investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $663.33. Read more …
Truist Financial downgraded shares of Gilead Sciences (NASDAQ:GILD) from a buy rating to a hold rating in a research report sent to investors on Thursday, MarketBeat.com reports. The brokerage currently has $82.00 target price on the biopharmaceutical company’s stock, down from their prior target price of $91.00.
Several other brokerages also recently weighed in on GILD. Barclays cut their price target on Gilead Sciences from $85.00 to $80.00 and set an equal weight rating on the stock in a research report on Monday, February 12th. Wells Fargo & Company cut their price target on Gilead Sciences from $90.00 to $84.00 and set an equal weight rating on the stock in a research report on Wednesday, February 7th. Royal Bank of Canada cut their price target on Gilead Sciences from $76.00 to $75.00 and set a sector perform rating on the stock in a research report on Wednesday, February 14th. Oppenheimer cut their price target on Gilead Sciences from $115.00 to $105.00 and set an outperform rating on the stock in a research report on Monday, February 12th. Finally, Cantor Fitzgerald lowered their target price on shares of Gilead Sciences from $80.00 to $78.00 and set a neutral rating on the stock in a research note on Wednesday, February 7th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Gilead Sciences presently has an average rating of Hold and an average target price of $85.86. Read more ...
Archive of Upgrades and Downgrades
Comments
Post a Comment